Kaitlin Lolie McLellan

Senior Associate
Norton Rose Fulbright US LLP

Houston
United States
T:+1 713 651 5285
Houston
United States
T:+1 713 651 5285
Kaitlin Lolie McLellan

Kaitlin Lolie McLellan

LinkedIn vCard

Related services and key industries


Biography

Kaitlin's practice focuses on domestic and international mergers and acquisitions, joint ventures, multijurisdictional corporate matters, restructurings and venture capital financing. Her representation encompasses companies and transactions in a variety of industries, including energy, financial institutions, technology and healthcare.

In the energy sector, Kaitlin advises domestic and international clients in the legal aspects of joint ventures, acquisitions and dispositions of upstream and downstream oil and gas companies and assets, as well as green energy companies.

In the healthcare sector, Kaitlin advises academic health science centers, hospital systems and bio-medical startup companies in joint ventures, collaboration agreements, sponsored research agreements and licensing arrangements, as well as acquisitions and divestitures.


Professional experience

Expand all Collapse all

JD, Vanderbilt University Law School, 2016
BBA, summa cum laude, Baylor University, 2013

While in law school, Kaitlin was a member of the Vanderbilt Journal of Transnational Law.

  • Texas State Bar

Energy

  • Representation of a major international oil and gas company in the divestiture of over US$1 billion of downstream assets
  • Representation of a major international oil and gas company in the development of a cross-border green energy joint venture.
  • Representation of large U.S. energy company in US$250 million acquisition of cross-border refinery assets
  • Representation of U.S. private hydrogen energy solutions company in the acquisition of U.S. private hydrogen centric company and related corporate restructurings
  • Representation of Victory Hill Capital Advisors, an English private equity company, in the acquisition of two Texas oil and gas terminal companies and related cross-border joint venture transactions with additional third parties
  • Representation of Saft America, a company of Total, in the acquisition of Go Electric, a U.S. based developer of distributed energy resiliency solutions for microgrids and C&I customers
  • Representation of Valero Energy Corporation in its US$470 million acquisition of Pure Biofuels del Peru S.A.C., the third largest fuels importer in Peru, including refined products terminals in Callao, near Lima, and in Paita, near Piura in northern Peru, and land adjacent to the Callao terminal, to support future expansion of the terminal's storage capacity, from Pegasus Capital Advisors L.P., PBF management and its minority shareholders
  • Representation of Southwest Electronic Energy, Inc. in its sale to Ultralife Corporation
  • Representation of a major international oil and gas company in the purchase of select refinery and other assets, including certain contracts
  • Representation of an NYSE-listed oil and gas company in a joint venture with a non-US partner to develop alternative plastics technology
  • Representation of an NYSE-listed oil and gas company in the unwinding of a refinery joint venture with a French counterparty
  • Representation of an international maritime company in the creation of multiple vessel pooling joint ventures with U.S. and non-US partners

Healthcare and life sciences

  • Representation of a large academic health science center in its collaboration agreement/joint venture with a major healthcare management investment firm
  • Representation of a large academic health science center in multiple medical start-up joint ventures as well as a major research joint venture
  • Representation of a pharmaceutical focused investment fund in multiple investments in startup medical device and pharmaceutical companies
  • Private companies licensing and development agreements for commercialization of patented technologies
  • Representation of a large academic health science center in its divestiture of a medical device company
  • Representation of a large hospital system in its divestiture of a business unit
  • Representation of a large hospital system in its cross-border research collaboration agreement/joint venture

Miscellaneous

  • A financial institution in its initial public offering
  • Public companies related to '34 Act compliance, Section 16 filings, and corporate governance
  • Start-up companies and venture capital funds in Series A and Series B financings
  • Publicly traded and privately held corporations, limited liability companies, and partnerships in buy-side and sell-side domestic and cross-border/international asset and equity acquisitions and restructurings
  • Publicly traded and privately held corporations in taxable and tax-free mergers
  • International relief organizations, private foundations, and public charities in establishing, maintaining, and terminating tax exempt status
  • Private companies developing joint ventures
  • Co-author, "INSIGHT: Not so risky business - How to increase transaction closing certainty," Bloomberg Law, September 22, 2020
  • "Good opportunities despite inherent difficulties," Bloomberg Law, July 2019
  • The Junior League of Houston
  • The Houston Bar Association